Terbutaline: Difference between revisions
(Created page with "==General== *Type: *Dosage Forms: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Pregnancy Rating: *Lac...") |
(Switch SMW query from broadtable to table format for better layout with TOC) |
||
| (21 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: | *Type: [[Beta 2 agonist]] | ||
*Dosage Forms: | *Dosage Forms: 1mg/mL injection | ||
==Adult Dosing== | ==Adult Dosing== | ||
===[[Preterm labor]]=== | |||
*0.25mg sq q20-30 min, up to 4 doses PRN contractions | |||
===Asthma/Bronchoconstriction=== | |||
*0.25mg sq q20 min, up to 3 doses | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===Asthma/Bronchoconstriction=== | |||
*0.005-0.01mg/kg to max 0.4mg SQ q15-20 min, up to 3 doses; may repeat in 2-6 hours | |||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: Category C | ||
*Lactation: | *Lactation: Not recommended | ||
*Renal Dosing | *Renal Dosing: n/a | ||
*Hepatic Dosing: n/a | |||
*Hepatic Dosing | |||
==Contraindications== | ==Contraindications== | ||
| Line 23: | Line 25: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*Black box warning against prolonged use for tocolysis (>48-72 hrs) | |||
*Cardiac arrhythmia | |||
===Common=== | ===Common=== | ||
*Agitation, tremor, hyperglycemia, hypokalemia | |||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: | *Onset: 6-15 minutes | ||
*Metabolism: | *Half-life: 11-16 hours | ||
*Excretion: | *Metabolism: Hepatic | ||
*Mechanism of Action: | *Excretion: Urine | ||
*Mechanism of Action: Beta 2 agonist, smooth muscle relaxant | |||
==Indications by Condition== | |||
''The following table is automatically generated from disease/condition pages across WikEM.'' | |||
{{#ask:[[Has DrugName::Terbutaline]] | |||
|?Has Indication=Indication | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|?Has Route=Route | |||
|?Has Population=Population | |||
|format=table | |||
|headers=plain | |||
|mainlabel=- | |||
|sort=Has Indication | |||
|limit=50 | |||
}} | |||
==See Also== | ==See Also== | ||
[[Asthma]], [[Preterm Labor]] | |||
== | ==References== | ||
Lexicomp | |||
<references/> | <references/> | ||
[[Category: | [[Category:Pharmacology]] | ||
Latest revision as of 21:55, 20 March 2026
General
- Type: Beta 2 agonist
- Dosage Forms: 1mg/mL injection
Adult Dosing
Preterm labor
- 0.25mg sq q20-30 min, up to 4 doses PRN contractions
Asthma/Bronchoconstriction
- 0.25mg sq q20 min, up to 3 doses
Pediatric Dosing
Asthma/Bronchoconstriction
- 0.005-0.01mg/kg to max 0.4mg SQ q15-20 min, up to 3 doses; may repeat in 2-6 hours
Special Populations
- Pregnancy Rating: Category C
- Lactation: Not recommended
- Renal Dosing: n/a
- Hepatic Dosing: n/a
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Black box warning against prolonged use for tocolysis (>48-72 hrs)
- Cardiac arrhythmia
Common
- Agitation, tremor, hyperglycemia, hypokalemia
Pharmacology
- Onset: 6-15 minutes
- Half-life: 11-16 hours
- Metabolism: Hepatic
- Excretion: Urine
- Mechanism of Action: Beta 2 agonist, smooth muscle relaxant
Indications by Condition
The following table is automatically generated from disease/condition pages across WikEM.
| Indication | Dose | Context | Route | Population |
|---|---|---|---|---|
| Acute asthma exacerbation | 0.25 mg SC/IM q20min x3 | Beta-2 agonist (longer-acting) | SC/IM | Adult |
| Preterm labor | 0.25mg SC q20-30min up to 4 doses PRN | Tocolytic | SC | Adult |
| Priapism | 0.25-0.5 mg SQ or 5-10 mg PO | Beta-agonist (adjunct) | SQ/PO | Adult |
See Also
References
Lexicomp